Berkshire Asset Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,830
Closed -$272K 241
2021
Q3
$272K Sell
2,830
-241
-8% -$26.3K 0.02% 205
2021
Q2
$328K Buy
3,071
+127
+4% +$12.5K 0.02% 187
2021
Q1
$264K Buy
2,944
+341
+13% +$37.5K 0.02% 200
2020
Q4
$262K Buy
+2,603
New +$194K 0.02% 192

Other funds holding CRNC

Berkshire Asset Management's CRNC Position: Q4 2021 in Review

Berkshire Asset Management sold out of Cerence (CRNC) in Q4 2021, closing a stake of 2,830 shares — an estimated $272K sold.

Berkshire Asset Management first reported a position in CRNC in Q4 2020 and held it in 4 quarters. The position peaked at $328K in Q2 2021. 360 funds tracked by Wall St. Rank hold CRNC as of Q4 2021.

  • Berkshire Asset Management reported no remaining Cerence position as of Q4 2021 after selling out during the quarter.
  • Berkshire Asset Management sold 2,830 Cerence shares in Q4 2021, an estimated $272K.
  • Berkshire Asset Management first reported a position in Cerence in Q4 2020 and held it in 4 quarters.
  • Berkshire Asset Management's Cerence position peaked at $328K in Q2 2021.
  • 360 funds tracked by Wall St. Rank held Cerence as of Q4 2021.

Based on Berkshire Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.